Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Intensive Treatment on Periodontitis in Aortic Stenosis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this clinical trial is to determine if standardized periodontal therapy can effectively slow the progression of aortic valve stenosis in adult patients diagnosed with moderate aortic valve stenosis and coexisting gingivitis or mild-to-moderate periodontitis. The main questions it aims to answer are: Can periodontal therapy slow the progression of aortic valve stenosis? Is chronic periodontitis an independent risk factor for the accelerated progression of aortic valve stenosis? Researchers will compare a group of patients receiving standardized periodontal therapy to a control group receiving only oral hygiene education to see if periodontal treatment results in a slower progression of aortic valve stenosis. Participants will undergo initial screening to confirm eligibility based on aortic valve peak velocity and periodontal status. They will then be randomly assigned to either the treatment group, which will receive comprehensive periodontal therapy, or the control group, which will receive only oral hygiene education. Participants will be followed up regularly over a 36-month period, with assessments including echocardiograms to monitor the progression of aortic valve stenosis, periodontal examinations to assess oral health status, and blood tests to measure relevant serum biomarkers. The study will also track any cardiovascular events and adverse events related to the interventions.

Who May Be Eligible (Plain English)

Who May Qualify: - Aged 18 years or older. - Aortic valve peak velocity (Vmax) between 3.0 and 3.9 m/s. - Diagnosis of aortic valve stenosis identified as degenerative aortic valve stenosis. - Presence of gingivitis or mild-to-moderate periodontitis confirmed by periodontal probing or panoramic dental radiography. - Willingness to participate in the study and signing of willing to sign a consent form. Who Should NOT Join This Trial: - End-stage renal disease with eGFR \< 15 ml/min/1.73m² (according to the Cockcroft \& Gault formula). - Pregnant, breastfeeding, and women of childbearing age (except those with effective contraception). - Factors that may affect study follow-up or adherence to periodontal therapy. - Patients unwilling or unable to undergo comprehensive periodontal treatment. - Patients who do not consent to participate in the study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Aged 18 years or older. * Aortic valve peak velocity (Vmax) between 3.0 and 3.9 m/s. * Diagnosis of aortic valve stenosis identified as degenerative aortic valve stenosis. * Presence of gingivitis or mild-to-moderate periodontitis confirmed by periodontal probing or panoramic dental radiography. * Willingness to participate in the study and signing of informed consent. Exclusion Criteria: * End-stage renal disease with eGFR \< 15 ml/min/1.73m² (according to the Cockcroft \& Gault formula). * Pregnant, breastfeeding, and women of childbearing age (except those with effective contraception). * Factors that may affect study follow-up or adherence to periodontal therapy. * Patients unwilling or unable to undergo comprehensive periodontal treatment. * Patients who do not consent to participate in the study.

Treatments Being Tested

PROCEDURE

Standard periodontal treatment protocol

Administering standard treatments for chronic periodontitis according to the current guidelines, including supragingival scaling, subgingival scaling, root planing, and periodontal flap surgery.

BEHAVIORAL

Oral hygiene education

Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.

Locations (1)

China National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China